nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—Coronary artery disease—Varenicline—nicotine dependence	0.0351	0.0384	CcSEcCtD
Tizanidine—Withdrawal symptom—Varenicline—nicotine dependence	0.0338	0.037	CcSEcCtD
Tizanidine—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.0283	0.031	CcSEcCtD
Tizanidine—Suicide attempt—Varenicline—nicotine dependence	0.0245	0.0268	CcSEcCtD
Tizanidine—NISCH—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.0207	0.24	CbGpPWpGaD
Tizanidine—Intestinal obstruction—Varenicline—nicotine dependence	0.0204	0.0223	CcSEcCtD
Tizanidine—Haematemesis—Varenicline—nicotine dependence	0.02	0.0219	CcSEcCtD
Tizanidine—Hyperlipidaemia—Varenicline—nicotine dependence	0.0193	0.0211	CcSEcCtD
Tizanidine—Menorrhagia—Varenicline—nicotine dependence	0.0188	0.0205	CcSEcCtD
Tizanidine—Scotoma—Varenicline—nicotine dependence	0.0183	0.02	CcSEcCtD
Tizanidine—Nephrolithiasis—Varenicline—nicotine dependence	0.0173	0.0189	CcSEcCtD
Tizanidine—Glycosuria—Varenicline—nicotine dependence	0.0171	0.0188	CcSEcCtD
Tizanidine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0154	0.0168	CcSEcCtD
Tizanidine—Thinking abnormal—Varenicline—nicotine dependence	0.0152	0.0166	CcSEcCtD
Tizanidine—Leukocytosis—Varenicline—nicotine dependence	0.0148	0.0162	CcSEcCtD
Tizanidine—Pulmonary embolism—Varenicline—nicotine dependence	0.0139	0.0152	CcSEcCtD
Tizanidine—Abnormal dreams—Varenicline—nicotine dependence	0.0137	0.015	CcSEcCtD
Tizanidine—Hypertonia—Varenicline—nicotine dependence	0.0122	0.0133	CcSEcCtD
Tizanidine—Mental disability—Varenicline—nicotine dependence	0.012	0.0132	CcSEcCtD
Tizanidine—Euphoric mood—Varenicline—nicotine dependence	0.0119	0.0131	CcSEcCtD
Tizanidine—Deafness—Varenicline—nicotine dependence	0.0113	0.0123	CcSEcCtD
Tizanidine—Eye pain—Varenicline—nicotine dependence	0.0112	0.0122	CcSEcCtD
Tizanidine—Renal failure acute—Varenicline—nicotine dependence	0.0109	0.0119	CcSEcCtD
Tizanidine—Arthritis—Varenicline—nicotine dependence	0.0104	0.0113	CcSEcCtD
Tizanidine—Cerebrovascular accident—Varenicline—nicotine dependence	0.0103	0.0113	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0101	0.011	CcSEcCtD
Tizanidine—Affect lability—Varenicline—nicotine dependence	0.00992	0.0109	CcSEcCtD
Tizanidine—Migraine—Varenicline—nicotine dependence	0.00992	0.0109	CcSEcCtD
Tizanidine—Psychotic disorder—Varenicline—nicotine dependence	0.00984	0.0108	CcSEcCtD
Tizanidine—Urinary retention—Varenicline—nicotine dependence	0.00958	0.0105	CcSEcCtD
Tizanidine—Mood swings—Varenicline—nicotine dependence	0.00955	0.0104	CcSEcCtD
Tizanidine—Liver function test abnormal—Varenicline—nicotine dependence	0.0093	0.0102	CcSEcCtD
Tizanidine—Dry skin—Varenicline—nicotine dependence	0.00924	0.0101	CcSEcCtD
Tizanidine—Hypokalaemia—Varenicline—nicotine dependence	0.00917	0.01	CcSEcCtD
Tizanidine—Asthma—Varenicline—nicotine dependence	0.00871	0.00953	CcSEcCtD
Tizanidine—Dysphagia—Varenicline—nicotine dependence	0.00871	0.00953	CcSEcCtD
Tizanidine—Angina pectoris—Varenicline—nicotine dependence	0.00849	0.00928	CcSEcCtD
Tizanidine—Bronchitis—Varenicline—nicotine dependence	0.00838	0.00917	CcSEcCtD
Tizanidine—Pollakiuria—Varenicline—nicotine dependence	0.00805	0.0088	CcSEcCtD
Tizanidine—Hyperglycaemia—Varenicline—nicotine dependence	0.00786	0.0086	CcSEcCtD
Tizanidine—Depression—Varenicline—nicotine dependence	0.00774	0.00847	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0077	0.00843	CcSEcCtD
Tizanidine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00766	0.00838	CcSEcCtD
Tizanidine—Myocardial infarction—Varenicline—nicotine dependence	0.00761	0.00833	CcSEcCtD
Tizanidine—Conjunctivitis—Varenicline—nicotine dependence	0.00755	0.00826	CcSEcCtD
Tizanidine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00735	0.00804	CcSEcCtD
Tizanidine—Sinusitis—Varenicline—nicotine dependence	0.00729	0.00797	CcSEcCtD
Tizanidine—Bradycardia—Varenicline—nicotine dependence	0.0071	0.00777	CcSEcCtD
Tizanidine—Hallucination—Varenicline—nicotine dependence	0.00694	0.00759	CcSEcCtD
Tizanidine—Urinary tract disorder—Varenicline—nicotine dependence	0.00689	0.00753	CcSEcCtD
Tizanidine—Connective tissue disorder—Varenicline—nicotine dependence	0.00685	0.0075	CcSEcCtD
Tizanidine—Urethral disorder—Varenicline—nicotine dependence	0.00683	0.00748	CcSEcCtD
Tizanidine—Erythema multiforme—Varenicline—nicotine dependence	0.00659	0.00721	CcSEcCtD
Tizanidine—Tinnitus—Varenicline—nicotine dependence	0.0065	0.00711	CcSEcCtD
Tizanidine—Cardiac disorder—Varenicline—nicotine dependence	0.00647	0.00708	CcSEcCtD
Tizanidine—Angiopathy—Varenicline—nicotine dependence	0.00633	0.00692	CcSEcCtD
Tizanidine—Immune system disorder—Varenicline—nicotine dependence	0.0063	0.00689	CcSEcCtD
Tizanidine—Mediastinal disorder—Varenicline—nicotine dependence	0.00628	0.00688	CcSEcCtD
Tizanidine—Arrhythmia—Varenicline—nicotine dependence	0.00623	0.00682	CcSEcCtD
Tizanidine—Mental disorder—Varenicline—nicotine dependence	0.00611	0.00668	CcSEcCtD
Tizanidine—Flatulence—Varenicline—nicotine dependence	0.00598	0.00654	CcSEcCtD
Tizanidine—Back pain—Varenicline—nicotine dependence	0.00587	0.00642	CcSEcCtD
Tizanidine—Muscle spasms—Varenicline—nicotine dependence	0.00584	0.00639	CcSEcCtD
Tizanidine—Vision blurred—Varenicline—nicotine dependence	0.00572	0.00626	CcSEcCtD
Tizanidine—Tremor—Varenicline—nicotine dependence	0.00569	0.00622	CcSEcCtD
Tizanidine—Ill-defined disorder—Varenicline—nicotine dependence	0.00563	0.00616	CcSEcCtD
Tizanidine—Anaemia—Varenicline—nicotine dependence	0.00561	0.00614	CcSEcCtD
Tizanidine—Agitation—Varenicline—nicotine dependence	0.00558	0.0061	CcSEcCtD
Tizanidine—Malaise—Varenicline—nicotine dependence	0.00547	0.00599	CcSEcCtD
Tizanidine—Vertigo—Varenicline—nicotine dependence	0.00545	0.00597	CcSEcCtD
Tizanidine—Syncope—Varenicline—nicotine dependence	0.00544	0.00596	CcSEcCtD
Tizanidine—Loss of consciousness—Varenicline—nicotine dependence	0.00533	0.00584	CcSEcCtD
Tizanidine—Convulsion—Varenicline—nicotine dependence	0.00526	0.00575	CcSEcCtD
Tizanidine—Hypertension—Varenicline—nicotine dependence	0.00524	0.00573	CcSEcCtD
Tizanidine—Arthralgia—Varenicline—nicotine dependence	0.00517	0.00565	CcSEcCtD
Tizanidine—Anxiety—Varenicline—nicotine dependence	0.00515	0.00563	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00513	0.00562	CcSEcCtD
Tizanidine—Discomfort—Varenicline—nicotine dependence	0.00511	0.00559	CcSEcCtD
Tizanidine—Dry mouth—Varenicline—nicotine dependence	0.00505	0.00553	CcSEcCtD
Tizanidine—Oedema—Varenicline—nicotine dependence	0.00495	0.00542	CcSEcCtD
Tizanidine—Infection—Varenicline—nicotine dependence	0.00492	0.00538	CcSEcCtD
Tizanidine—Shock—Varenicline—nicotine dependence	0.00487	0.00533	CcSEcCtD
Tizanidine—Nervous system disorder—Varenicline—nicotine dependence	0.00486	0.00532	CcSEcCtD
Tizanidine—Thrombocytopenia—Varenicline—nicotine dependence	0.00485	0.00531	CcSEcCtD
Tizanidine—Tachycardia—Varenicline—nicotine dependence	0.00483	0.00529	CcSEcCtD
Tizanidine—Skin disorder—Varenicline—nicotine dependence	0.00481	0.00526	CcSEcCtD
Tizanidine—Hyperhidrosis—Varenicline—nicotine dependence	0.00479	0.00524	CcSEcCtD
Tizanidine—Hypotension—Varenicline—nicotine dependence	0.00463	0.00506	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00451	0.00494	CcSEcCtD
Tizanidine—Dyspnoea—Varenicline—nicotine dependence	0.00442	0.00483	CcSEcCtD
Tizanidine—Somnolence—Varenicline—nicotine dependence	0.0044	0.00482	CcSEcCtD
Tizanidine—Dyspepsia—Varenicline—nicotine dependence	0.00436	0.00477	CcSEcCtD
Tizanidine—Fatigue—Varenicline—nicotine dependence	0.00427	0.00467	CcSEcCtD
Tizanidine—Constipation—Varenicline—nicotine dependence	0.00424	0.00464	CcSEcCtD
Tizanidine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00421	0.0489	CbGpPWpGaD
Tizanidine—Feeling abnormal—Varenicline—nicotine dependence	0.00408	0.00447	CcSEcCtD
Tizanidine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00405	0.00443	CcSEcCtD
Tizanidine—Urticaria—Varenicline—nicotine dependence	0.00394	0.00431	CcSEcCtD
Tizanidine—Body temperature increased—Varenicline—nicotine dependence	0.00392	0.00428	CcSEcCtD
Tizanidine—Abdominal pain—Varenicline—nicotine dependence	0.00392	0.00428	CcSEcCtD
Tizanidine—Hypersensitivity—Varenicline—nicotine dependence	0.00365	0.00399	CcSEcCtD
Tizanidine—Asthenia—Varenicline—nicotine dependence	0.00355	0.00389	CcSEcCtD
Tizanidine—Pruritus—Varenicline—nicotine dependence	0.0035	0.00383	CcSEcCtD
Tizanidine—Diarrhoea—Varenicline—nicotine dependence	0.00339	0.00371	CcSEcCtD
Tizanidine—Dizziness—Varenicline—nicotine dependence	0.00328	0.00358	CcSEcCtD
Tizanidine—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00319	0.037	CbGpPWpGaD
Tizanidine—Vomiting—Varenicline—nicotine dependence	0.00315	0.00345	CcSEcCtD
Tizanidine—Rash—Varenicline—nicotine dependence	0.00312	0.00342	CcSEcCtD
Tizanidine—Dermatitis—Varenicline—nicotine dependence	0.00312	0.00341	CcSEcCtD
Tizanidine—ADRA2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00298	0.0346	CbGpPWpGaD
Tizanidine—Nausea—Varenicline—nicotine dependence	0.00294	0.00322	CcSEcCtD
Tizanidine—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00268	0.0311	CbGpPWpGaD
Tizanidine—ADRA2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0025	0.029	CbGpPWpGaD
Tizanidine—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00242	0.0281	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00217	0.0252	CbGpPWpGaD
Tizanidine—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00203	0.0236	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00203	0.0236	CbGpPWpGaD
Tizanidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00175	0.0203	CbGpPWpGaD
Tizanidine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00173	0.02	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00165	0.0192	CbGpPWpGaD
Tizanidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00142	0.0165	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00132	0.0153	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00123	0.0143	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000998	0.0116	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000916	0.0106	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000856	0.00994	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00085	0.00988	CbGpPWpGaD
Tizanidine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000799	0.00928	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000794	0.00922	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000753	0.00874	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000744	0.00864	CbGpPWpGaD
Tizanidine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000743	0.00862	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000729	0.00846	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000695	0.00807	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000695	0.00807	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000681	0.0079	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000675	0.00784	CbGpPWpGaD
Tizanidine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000662	0.00769	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000645	0.00749	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000631	0.00733	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.000619	0.00719	CbGpPWpGaD
Tizanidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000615	0.00714	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000584	0.00678	CbGpPWpGaD
Tizanidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000574	0.00667	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000564	0.00655	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000555	0.00644	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000553	0.00642	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000545	0.00633	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.00053	0.00615	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000527	0.00612	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000518	0.00602	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000512	0.00595	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000503	0.00584	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000495	0.00575	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000492	0.00571	CbGpPWpGaD
Tizanidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000466	0.00542	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000443	0.00514	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000421	0.00489	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000402	0.00467	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000401	0.00466	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0004	0.00464	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000399	0.00463	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.000375	0.00435	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000373	0.00433	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000314	0.00364	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000313	0.00364	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000304	0.00353	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000303	0.00352	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000293	0.0034	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	0.000292	0.0034	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	0.000287	0.00334	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000285	0.00331	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000277	0.00321	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	0.000266	0.00309	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000258	0.003	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000238	0.00276	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000238	0.00276	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000233	0.00271	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000227	0.00263	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000216	0.00251	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000212	0.00246	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.00021	0.00244	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000206	0.00239	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.000195	0.00226	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	0.000192	0.00223	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.000187	0.00217	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	0.000182	0.00211	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	0.000174	0.00203	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000172	0.002	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000168	0.00195	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	0.000157	0.00182	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000156	0.00181	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000148	0.00172	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000142	0.00165	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000129	0.0015	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000128	0.00148	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.000122	0.00141	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	0.000114	0.00132	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	9.23e-05	0.00107	CbGpPWpGaD
